Showing posts with label FOLR1. Show all posts
Showing posts with label FOLR1. Show all posts
Tuesday, April 17, 2012
financial news: ImmunoGen Says IND For Anticancer Compound IMGN853 Is Now Active
ImmunoGen Says IND For Anticancer Compound IMGN853 Is Now Active
(RTTNews.com) - ImmunoGen, Inc. (IMGN) announced that the Investigational New Drug, or IND, application for its IMGN853 product candidate is now active. IMGN853 is a potential new therapeutic for ovarian cancer, non-small cell lung cancer and other epithelial malignancies which over-express folate receptor 1, or FOLR1.
The company expects Phase I evaluation of IMGN853 to commence in the middle of 2012.....
Subscribe to:
Posts
(
Atom
)
